MSAM
BIIB icon

Moloney Securities Asset Management’s Biogen BIIB Stock Holding History

Moloney Securities Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,537
Closed -$356K – 490
2024
Q2 		$356K Buy
1,537
+140
+10% +$30.4K 0.05% 320
2024
Q1 		$301K Buy
+1,397
New +$327K 0.05% 342
2018
Q1 		– Sell
-744
Closed -$237K – 294
2017
Q4 		$237K Hold
744
– – 0.1% 217
2017
Q3 		$233K Hold
744
– – 0.1% 223
2017
Q2 		$202K Sell
744
-50
-6% -$13.2K 0.1% 227
2017
Q1 		$217K Buy
794
+41
+5% +$11.6K 0.11% 213
2016
Q4 		$214K Buy
+753
New +$223K 0.13% 189

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Moloney Securities Asset Management's BIIB Position: Q3 2024 in Review

Moloney Securities Asset Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,537 shares — an estimated $356K sold.

Moloney Securities Asset Management first reported a position in BIIB in Q4 2016 and held it in 7 quarters. The position peaked at $356K in Q2 2024. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Moloney Securities Asset Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Moloney Securities Asset Management sold 1,537 Biogen shares in Q3 2024, an estimated $356K.
  • Moloney Securities Asset Management first reported a position in Biogen in Q4 2016 and held it in 7 quarters.
  • Moloney Securities Asset Management's Biogen position peaked at $356K in Q2 2024.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Moloney Securities Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.